Login / Signup

Quantifying Diversity and Representation in Pivotal Trials Leading to Marketing Authorization in Europe.

Zachary P SmithEmily BottoKenneth Getz
Published in: Therapeutic innovation & regulatory science (2022)
Guidelines encouraging the reporting of patient demographic data are insufficient and availability of the data is problematic. The available data suggest that under-representation in pivotal trials is widespread.
Keyphrases
  • electronic health record
  • big data
  • data analysis
  • emergency department
  • neural network